Both in Pharmaceuticals
Contineum Therapeutics vs Galectin Therapeutics
Over the past year CTNM returned −9.0% and GALT returned −44.2%; their daily moves had a correlation of 0.19.
CTNM −9.0% GALT −44.2%Growth of $1, one year, split-adjusted
| Metric | CTNM | GALT |
|---|---|---|
| Price | $9.69 | $3.35 |
| Market cap | $364.5M | $337.8M |
| Today | +1.36% | +0.60% |
| 1 month | −23.8% | −10.2% |
| 6 months | −32.7% | +50.2% |
| Year to date | −15.2% | −19.5% |
| 1 year | −12.0% | −42.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $236.6M | -$19.8M |
| Dividend yield | — | — |
| Volatility (60d) | 117.5% | 60.7% |
| Short % of float | 13.1% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).